Experimental cancer drug offered outside trials
NCT ID NCT03756311
Summary
This program provided access to an experimental cancer treatment called NanoPac for patients with advanced pancreatic, prostate, or lung cancer who couldn't join regular clinical trials. It was designed to offer treatment options when standard trials weren't available. The program is no longer accepting new patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.